VMRD Launches Rapid Horse-Side Insulin Test to Decrease Risk of Laminitis in Metabolic Horses
Pullman, WA, August 28, 2026 --(PR.com)-- VMRD, Inc. is thrilled to share the launch of their exciting new test for horse-side measurement of insulin in horses. Run on the same palm-sized reader as VMRD SAA and Foal IgG, this highly portable multi-functional testing platform embodies VMRD’s vision of improving animal health through high-quality, practical diagnostics.
Equine Metabolic Syndrome and insulin dysregulation are incredibly common in the equine population, with potentially extreme consequences when elevated insulin leads to hyperinsulinemia-associated laminitis. Prevention and management of hyperinsulinemia are therefore vital, which necessitates accurate and timely evaluation of insulin levels.
“Laminitis in horses, otherwise known as founder, can be extremely devastating for horses and their owners,” explains Veterinary Affairs Manager Siddra Hines, DVM, PhD, DACVIM. “Measuring insulin horse-side can help evaluate a horse’s risk and guide management decisions surrounding feed and turnout to decrease that risk.”
The brand-new VMRD Insulin test runs in 15 minutes using whole blood, offering a simple, horse-side solution for assessment that supports ongoing collaboration between equine veterinarians and their clients. Resting insulin levels can be screened on-the-spot and used to evaluate the effectiveness of management strategies such as limiting turnout and changing feed, and same-day results from an oral sugar test allows immediate action to be taken to decrease risk of laminitis.
Dr. Hines says, “This new test provides immediate information about insulin status that enables veterinarians and their clients to work together and make the best possible management decisions. This also allows horse owners to directly see the impact of the hard work they invest in maintaining their horses’ well-being as they successfully lower insulin levels in an at-risk horse.”
For more information on point-of-care products from VMRD, including Insulin, Foal IgG, and SAA, please visit our website at vmrd.com/poc or contact us at vets@vmrd.com
Equine Metabolic Syndrome and insulin dysregulation are incredibly common in the equine population, with potentially extreme consequences when elevated insulin leads to hyperinsulinemia-associated laminitis. Prevention and management of hyperinsulinemia are therefore vital, which necessitates accurate and timely evaluation of insulin levels.
“Laminitis in horses, otherwise known as founder, can be extremely devastating for horses and their owners,” explains Veterinary Affairs Manager Siddra Hines, DVM, PhD, DACVIM. “Measuring insulin horse-side can help evaluate a horse’s risk and guide management decisions surrounding feed and turnout to decrease that risk.”
The brand-new VMRD Insulin test runs in 15 minutes using whole blood, offering a simple, horse-side solution for assessment that supports ongoing collaboration between equine veterinarians and their clients. Resting insulin levels can be screened on-the-spot and used to evaluate the effectiveness of management strategies such as limiting turnout and changing feed, and same-day results from an oral sugar test allows immediate action to be taken to decrease risk of laminitis.
Dr. Hines says, “This new test provides immediate information about insulin status that enables veterinarians and their clients to work together and make the best possible management decisions. This also allows horse owners to directly see the impact of the hard work they invest in maintaining their horses’ well-being as they successfully lower insulin levels in an at-risk horse.”
For more information on point-of-care products from VMRD, including Insulin, Foal IgG, and SAA, please visit our website at vmrd.com/poc or contact us at vets@vmrd.com
Contact
VMRD, Inc.
Siddra Hines
509-334-5815
vmrd.com/
Siddra Hines
509-334-5815
vmrd.com/
Contact
Categories